Nigeria to Receive First Shipment of Malaria Vaccines This Thursday

Nigeria is poised to take a significant step in its fight against malaria, as the country is set to receive its first shipment of malaria vaccines on Thursday. The National Primary Health Care Development Agency (NPHCDA) confirmed that the vaccines will arrive in Abuja, where they will be officially received by the Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate.

This delivery is part of a broader initiative by the World Health Organization (WHO) to supply malaria vaccines to African countries with high infection rates. Nigeria, which bears the largest global malaria burden, is expected to benefit immensely from the introduction of these vaccines.

The initial phase of the vaccine rollout will focus on Bayelsa and Kebbi states, as health authorities assess the deployment strategy. Speaking on the plan, Prof. Pate explained, “We’ve secured some doses of this malaria vaccine which will be deployed to Bayelsa and Kebbi states so that we see how the rollout goes, and then in parallel, identify where the money is going to come from.”

Two vaccines are part of this groundbreaking effort: RTS,S/AS01 (Mosquirix) and the newly approved R21/Matrix-M, which has shown a promising efficacy rate of 77% in trials. The rollout will serve as a pilot to determine the effectiveness of the vaccines in reducing malaria cases and deaths, particularly in the most vulnerable regions.

Malaria continues to pose a severe public health threat in Nigeria, with 97% of the population at risk. The country accounts for 27% of the global malaria cases and 31% of deaths worldwide. In southern Nigeria, the disease is transmitted year-round, while northern regions experience seasonal transmission, largely caused by Anopheles mosquitoes.

The government has laid out a plan to prioritize vaccine distribution in rural areas, where healthcare access is often limited. The NPHCDA estimates that covering the targeted population will cost approximately $250 million, with funding efforts ongoing to ensure the program’s expansion after the pilot phase.

Despite recent efforts, malaria remains a major issue. Although prevalence among children under five dropped from 42% in 2010 to 23% in 2018, rural areas continue to experience higher rates compared to urban centers. The government’s National Malaria Elimination Programme (NMEP) aims to reduce malaria prevalence below 10% and achieve fewer than 50 deaths per 1,000 people by 2025.

Experts remain optimistic that the introduction of these vaccines, combined with ongoing preventive measures, could dramatically reduce the burden of malaria in Nigeria, bringing the country closer to the vision of a malaria-free Africa.